Drug
Icp 538
Icp 538: highest development phase Phase 1, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-538 Tablets NCT07535099 | Phase 1 | Health Services Research |
Latest
No recent events.
Follow Icp 538 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.